Clinical trial
Combination Anti-thrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease: Protocol for a Pilot Randomized Trial
NCT04142125 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combination Anti-thrombotic Treatment for Prevention of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease: Protocol for a Pilot Randomized Trial
- Lead sponsor
- Population Health Research Institute
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 3, 2020
- Completion date
- September 18, 2023
- Enrollment
- 101 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
intracranial atherosclerotic disease, ischemic stroke